Demencia    Depresión    Enfermedad de Parkinson    Epilepsia    Esclerosis múltiple    Esquizofrenia    Ictus    Migraña    Trastornos de ansiedad  
  Trastorno bipolar    Trastorno de pánico    Trastornos del sueño  
 

Otros mapas del encéfalo
    Prosencéfalo
    Mesencéfalo
    Rombencéfalo
    Médula espinal
    Lóbulos
    Sistema límbico
    Sección coronal
    Vasculatura del cerebro

 

Trastorno de pánico

Referencias

Angst J. Depression and anxiety: implications for nosology, course and treatment. J Clin Psychiatry 1997; 58 (Suppl 8): 3-5.

Bell CJ, Nutt DJ. Serotonin and panic. Br J Psychiatry 1998; 172: 465-471.

Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995; 10: 45-49.

den Boer JA, Westenberg HGM. Serotonin function in panic disorder, a double-blind placebo controlled study with fluvoxamine and ritanserin. Psychopharmacology (Berl) 1990; 102: 85-94.

DeVane CL. The place of selective serotonin reuptake inhibitors in the treatment of panic disorder. Pharmacotherapy 1997; 17(2): 282-292.

EmmelkampPMG, Wessels H. Flooding in imagination vs flooding in vivo: a comparison with agoraphobia. Behaviour Res Ther 1975; 13: 7-15.

Estivill 2001- Human Genome project

Gorman JM, Keck PE Jr, Herschfeld RMA, Keller MB. The use of newer antidepressants for panic disorder. J Clin Psychiatry 1997; 58 (Suppl 14): 54-58.

Gorman JM, Liebowitz MR, Fyer AJ, et al. An open trial of fluoxetine in the treatment of panic attacks. J Clin Psychopharmacol 1987; 7: 329-332.

Gorman JM, Wolkow R. Sertraline as a treatment for panic disorder. Neuropsychopharmacology 1994; 10: 35-197.

Hoehn-Saric R, McLeod DR, Hipsley PA. Effect of fluvoxamineon panic disorder. J Clin Psychopharmacol 1993; 50: 44-50.

Johnson MR, Lyiard RB, Ballenger JC. Panic disorder: pathophysiology and drug treatment. Drugs 1995; 49: 328-344.

Joubert AF, Stein DJ. SSRIs in the treatment of anxiety disorders. Rev Contemp Psychopharm 1999; 10 (2): 79-131.

Katerndahl DA, Realini JP. Lifetime prevalence of panic states. Am J Psychiatry 1993; 150: 246-249.

Lepola U. Alcohol and depression in panic disorder. Acta Psychiatr Scand Suppl 1994; 377: 33-35.

Lepola UM, Wade AG, Leinonen EV, et al. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry. 1998; 59(10): 528-534.

Muzina DJ, Malone DA. Panic disorder in primary care: a cause of unexplained symptoms. Clev Clin J Med 1997; 64(8): 437-443.

Noyes R, Garvey MJ, Cook BL. Follow-up study of aptients with panic disorder or agoraphobia with panic attacks treated with tricyclic antidepressants. J Affect Disord 1989; 16: 249-257.

Oehrberg S, Christiansen PE, Behnke K, et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study. Br J Psychiatry 1995; 167: 374-379.

Schneier FR, Liebowitz MR, Davies SO, et al. Fluoxetine in panic disorder. J Clin Psychopharmacol 1990; 10: 119-121.

Sheehan DV, Raj BA. Panic disorder in primary care: a US perspective. Primary Care Psychiatry 1998; 4: 10-28.

Starcevic V, Uhlenhuth EH, Kellner R, Pathak D. Comorbidity in panic disorder. II: Chronology of appearance and pathogenic comorbidity. Psychiatry Res 1993; 46: 285-293.

Tiller JWG, Bouwer C, Behnke K. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder. Int Clin Psychopharmacol 1997; 12 (Suppl 6): 27-30

Wade AG, Lepola U, Koponen HJ, Pedersen V, Pedersen T. The effect of citalopram in panic disorder. Br J Psychiatry 1997; 170: 549-553.

Yonkers KA, Zlotnick C, Allsworth AB, Warshaw M, Shea T, Keller MB. Is the course of panic disorder the same in women and men? Am J Psychaitry 1998; 155: 596-602.

 

 

 

 

   Comentarios       Mapa del sitio        Ayuda        Página principal        Junta editorial